141 related articles for article (PubMed ID: 20357529)
21. Hepatitis A seroprevalence in Erzurum, Turkey.
Yilmaz A
Ann Agric Environ Med; 2020 Sep; 27(3):481-484. PubMed ID: 32955233
[TBL] [Abstract][Full Text] [Related]
22. Laboratory characteristics of recent hepatitis A in Korea: ongoing epidemiological shift.
Moon HW; Cho JH; Hur M; Yun YM; Choe WH; Kwon SY; Lee CH
World J Gastroenterol; 2010 Mar; 16(9):1115-8. PubMed ID: 20205283
[TBL] [Abstract][Full Text] [Related]
23. HAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil.
da Silva EF; Mazo DF; Oliveira CP; Medeiros RP; Carrilho FJ; Pessôa MG
Ann Hepatol; 2016; 15(5):691-5. PubMed ID: 27493107
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of hepatitis A virus antibody in a population aged 0-30 years in Shanghai, China: implications for hepatitis A immunization.
Zhu Y; Yuan Z; Zhao Q; Chen G; Xu B
Epidemiol Infect; 2013 Mar; 141(3):556-62. PubMed ID: 22687628
[TBL] [Abstract][Full Text] [Related]
25. High prevalence of anti-hepatitis A virus immunoglobulin G antibody among healthcare facility attendees in Osogbo, Nigeria.
Sule WF; Kajogbola AT; Adewumi MO
J Immunoassay Immunochem; 2013; 34(1):75-82. PubMed ID: 23323983
[TBL] [Abstract][Full Text] [Related]
26. A nationwide seroprevalence of total antibody to hepatitis A virus from 2005 to 2009: age and area-adjusted prevalence rates.
Lee D; Ki M; Lee A; Lee KR; Park HB; Kim CS; Yoon BY; Kim JH; Lee YS; Jeong SH
Korean J Hepatol; 2011 Mar; 17(1):44-50. PubMed ID: 21494077
[TBL] [Abstract][Full Text] [Related]
27. Seroprevalence of antibodies against hepatitis A (anti-HAV) in Singapore: the NFDD experience.
Fock KM; Tay HH; Phua KB; Guan R; Chia SC; Chong R; Chee AE; Chew CN
Singapore Med J; 1995 Feb; 36(1):26-7. PubMed ID: 7570129
[TBL] [Abstract][Full Text] [Related]
28. Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance.
Yanez LA; Lucero NS; Barril PA; Díaz Mdel P; Tenaglia MM; Spinsanti LI; Nates SV; Isa MB; Ré VE
J Clin Virol; 2014 Jan; 59(1):38-43. PubMed ID: 24332411
[TBL] [Abstract][Full Text] [Related]
29. Seroprevalence of hepatitis A virus antibodies in Turkish and Moroccan children in Rotterdam.
Richardus JH; Vos D; Veldhuijzen IK; Groen J
J Med Virol; 2004 Feb; 72(2):197-202. PubMed ID: 14695660
[TBL] [Abstract][Full Text] [Related]
30. Incidence and seroprevalence of hepatitis A virus infections among young Korean soldiers.
Kang CI; Choi CM; Park TS; Lee DJ; Oh MD; Choe KW
J Korean Med Sci; 2007 Jun; 22(3):546-8. PubMed ID: 17596668
[TBL] [Abstract][Full Text] [Related]
31. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
Anand AC; Nagpal AK; Seth AK; Dhot PS
J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
[TBL] [Abstract][Full Text] [Related]
32. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children.
Al-Aziz AM; Awad MA
East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074
[TBL] [Abstract][Full Text] [Related]
33. [The age-specific seroprevalence of hepatitis A virus antibody in Korea].
Song YB; Lee JH; Choi MS; Koh KC; Paik SW; Yoo BC; Choi YH; Sohn HJ; Lee KH; Rhee JC
Korean J Hepatol; 2007 Mar; 13(1):27-33. PubMed ID: 17380072
[TBL] [Abstract][Full Text] [Related]
34. Routine testing for IgG antibodies against hepatitis A virus in Israel.
Samuels N
BMC Public Health; 2005 Jun; 5():60. PubMed ID: 15935104
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy.
John A; Chatni S; Narayanan VA; Balakrishnan V; Nair P
J Indian Med Assoc; 2009 Dec; 107(12):859-61. PubMed ID: 20509469
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong.
Wong KH; Liu YM; Ng PS; Young BW; Lee SS
J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755
[TBL] [Abstract][Full Text] [Related]
37. [Hepatitis A immunity in refugees in Germany during the current exodus].
Jablonka A; Solbach P; Happle C; Hampel A; Schmidt RE; Behrens GMN
Med Klin Intensivmed Notfmed; 2017 May; 112(4):347-351. PubMed ID: 27457821
[TBL] [Abstract][Full Text] [Related]
38. Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?
Duseja A; Sharma S; Das K; Dhiman RK; Chawla YK
Trop Gastroenterol; 2004; 25(4):162-3. PubMed ID: 15912973
[TBL] [Abstract][Full Text] [Related]
39. Immunity to hepatitis A virus among working professionals in Poland - Results of a 3-year serological survey 2013-2015.
Juszczyk G; Czerw AI; Walewska-Zielecka B; Mikos M; Banaś T; Deptała A; Ślusarczyk J
Ann Agric Environ Med; 2018 Sep; 25(3):572-575. PubMed ID: 30260171
[TBL] [Abstract][Full Text] [Related]
40. Exposure to hepatitis E virus, hepatitis A virus and Borrelia spp. infections in forest rangers from a single forest district in western Poland.
Bura M; Bukowska A; Michalak M; Bura A; Nawrocki MJ; Karczewski M; Mozer-Lisewska I
Adv Clin Exp Med; 2018 Mar; 27(3):351-355. PubMed ID: 29533542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
